What did Olympus Corporation pay for Taewoong Medical?

Olympus Corporation acquired Taewoong Medical for $255.5M in 2023 (25.6x EBITDA), equivalent to 5.10x revenue. Target revenue was approximately $50.0M. Target EBITDA was approximately $10.0M.

What does Taewoong Medical do?

Taewoong Medical is a medical devices business.

What multiple did Olympus Corporation pay for Taewoong Medical?

25.6x EBITDA and 5.10x revenue, based on disclosed deal value of $255.5M and disclosed financials.

M&A TRANSACTION · 2023

Taewoong Medical acquired by Olympus Corporation

$255.5M· 25.6x EBITDA· 5.10x revenue

Target

Taewoong Medical

Acquirer

Olympus Corporation

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$50.0M

EBITDA

$10.0M

Deal Value

$255.5M

EV/EBITDA

25.6x

Context

This $255.5M acquisition of Taewoong Medical by Olympus Corporation sits in the medical devices sub-vertical. The 25.6x EBITDA multiple paid in 2023 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub. Olympus Corporation is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.

Source

Data sourced from Press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the Taewoong Medical acquisition.

Citation: ExitValue.ai. (2023). Taewoong Medical acquired by Olympus Corporation. https://exitvalue.ai/deals/taewoong-medical-acquired-by-olympus-corporation-hc-2023-0051